Lilly's GLP-1 Drug Tirzepatide Injection Receives Approval for New Combination Therapy with Insulin - 7x24

7 x 24 Track global technological trends

Hot Topic

Day

News Topic

Lilly's GLP-1 Drug Tirzepatide Injection Receives Approval for New Combination Therapy with Insulin

3 week ago / Read about 0 minute

Author：小编

Lilly's GLP-1 drug, tirzepatide injection (brand name: Mounjaro), has garnered approval from China's National Medical Products Administration for an expanded therapeutic indication. This approval allows for the use of tirzepatide in combination with insulin (with or without oral hypoglycemic agents), in conjunction with dietary control and exercise, to enhance glycemic management in adult patients diagnosed with type 2 diabetes.

Previous page：Hong Kong Securities Market Implements Reduced Min...

Next page：Fosun Pharma Secures License Agreement with Neuroc...

Return to List

Hot Reading

1 day ago

Dex is an AI-powered camera device that helps children learn new languages

1 day ago

Founder of Google's Generative AI Team Says Don't Even Bother Getting a Law or Medical Degree, Because AI's Going to Destroy Both Those Careers Before You Can Even Graduate

2 day ago

Databricks CEO says fresh $1B will help him attack a new AI database market

1 day ago

After Disastrous GPT-5, Sam Altman Pivots to Hyping Up GPT-6